Literature DB >> 3257194

Increased resistance of the rat gastric mucosa to hemorrhagic damage after exposure to an irritant. Role of the "mucoid cap" and prostaglandin synthesis.

J L Wallace1.   

Abstract

This study examined the contribution of the "mucoid cap" that forms on the gastric mucosal surface after the application of an irritant to the increased resistance of the mucosa to damage induced by a subsequent application of ethanol ("adaptive cytoprotection"). Furthermore, the role of prostaglandins in the mechanism of this adaptation was examined. Hemorrhagic necrosis involving greater than 30% of the mucosa was induced by the topical application of 70% ethanol. Exposure of the mucosa to 1 M NaCl before ethanol application resulted in a 98% reduction in hemorrhagic necrosis. Removal of the mucoid cap that formed after application of the NaCl did not cause a reduction of the protective effects. Similarly, pretreatment with indomethacin did not reverse the protection, despite causing a 77% inhibition of gastric cyclooxygenase activity. The present study confirms that the application of an irritant to the gastric mucosa results in a significant increase in the resistance of the mucosa to hemorrhagic damage induced by ethanol. Although the mucoid cap that forms after irritation of the mucosa may play a role in promoting restitution, it does not appear to be responsible for the resistance to hemorrhagic necrosis. Prostaglandin synthesis by the gastric mucosa also does not appear to play a major role in the mechanism of adaptive cytoprotection.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3257194     DOI: 10.1016/0016-5085(88)90605-1

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  24 in total

Review 1.  Mechanistic aspects of gastric cytoprotection--a review.

Authors:  A Terano
Journal:  Gastroenterol Jpn       Date:  1992-04

2.  Comparison of the ulcerogenic properties of tepoxalin with those of non-steroidal anti-inflammatory drugs (NSAIDs).

Authors:  J L Wallace; G Cirino; C Cicala; D W Anderson; D Argentieri; R J Capetola
Journal:  Agents Actions       Date:  1991-09

Review 3.  Peptic ulcer--an infectious disease?

Authors:  W L Peterson
Journal:  West J Med       Date:  1990-02

4.  Histological study of mechanisms of adaptive cytoprotection on ethanol-induced mucosal damage in rat stomachs.

Authors:  J K Ko; C H Cho
Journal:  Dig Dis Sci       Date:  1998-06       Impact factor: 3.199

5.  Gastroprotection by 4-methylpyrazole against ethanol in humans.

Authors:  G Iaquinto; M Del Tacca; L Cuccurullo; M C Parodi; N Giardullo; V D'onofrio; G Natale; D Carignani; F Ferraraccio; S Szabo
Journal:  Dig Dis Sci       Date:  1998-04       Impact factor: 3.199

6.  Glutathione modulation changes the penetration of N-[3H]methyl-N-nitro-N-nitrosoguanidine into gastric mucosa of rats.

Authors:  K K Ovrebø; A Svardal; S Kvinnsland; K Grong; K Svanes; H Sørbye
Journal:  Dig Dis Sci       Date:  1999-10       Impact factor: 3.199

7.  Blood flow and mucoid cap protect against penetration of carcinogens into superficially injured gastric mucosa of rats.

Authors:  H Sørbye; K Ovrebø; H Gislason; S Kvinnsland; K Svanes
Journal:  Dig Dis Sci       Date:  1995-08       Impact factor: 3.199

8.  Roles of Ca2+ and protein kinase C in regulation of prostaglandin E2 release by cultured rabbit gastric epithelial cells.

Authors:  S Ota; Y Hata; A Terano; K Yoshiura; H Hiraishi; T Kawabe; H Mutoh; S Shiina; T Sugimoto
Journal:  Dig Dis Sci       Date:  1993-08       Impact factor: 3.199

9.  Stimulation of prostaglandin biosynthesis mediates gastroprotective effect of rebamipide in rats.

Authors:  A Kleine; S Kluge; B M Peskar
Journal:  Dig Dis Sci       Date:  1993-08       Impact factor: 3.199

10.  Cholecystokinin is a potent protective agent against alcohol-induced gastric injury in the rat. Role of endogenous prostaglandins.

Authors:  D W Mercer; J M Cross; J C Barreto; N H Strobel; D H Russell; T A Miller
Journal:  Dig Dis Sci       Date:  1995-03       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.